As of Jan 21, 2025, the Utah Medical Products stock's PE ratio is 14.7. This results from the current EPS of $4.27 and stock price of $62.78. The P/E ratio has a decrease of 10% from the past four quarters average of 16.3.
The PE ratio of Utah Medical Products has averaged 22.61 over the last ten years. The current PE ratio of 14.7 is 35% below the historical average. Over the past ten years, UTMD's PE ratio was at its highest in the Jun 2018 quarter at 43.37, when the stock price was $110.15 and the EPS was $2.54. The lowest value was in the Jun 2024 quarter, when it reached 15.43 with a price of $66.81 and an EPS of $4.33.
Maximum annual increase: 62.98% in 2019
Maximum annual decrease: -52.97% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 18.39 | -17.12% |
2022 | 22.19 | -10.13% |
2021 | 24.69 | -13.61% |
2020 | 28.58 | 4.88% |
2019 | 27.25 | 62.98% |
2018 | 16.72 | -52.97% |
2017 | 35.55 | 57.86% |
2016 | 22.52 | 21.53% |
2015 | 18.53 | -6.18% |
2014 | 19.75 | 5.73% |
The current PE ratio of UTMD is below the 3, 5 and 10-year averages.
UTMD's PE ratio is lower than its peer stocks JNJ and COO. Utah Medical Products is presently trading at a lower PE ratio (14.7) than its peer group average of 35.21.
Stock name | PE ratio | Market cap |
---|---|---|
UTMD Utah Medical Products Inc | 14.73 | $213.37M |
CNMD CONMED Corp | 16.59 | $2.19B |
JNJ Johnson & Johnson | 24.06 | $349.37B |
TFX Teleflex Inc | 35.69 | $8.39B |
COO Cooper Companies Inc | 48.32 | $19B |
MMSI Merit Medical Systems Inc | 50.64 | $6.11B |
The price to earnings ratio for UTMD stock is 14.7 as of Jan 21, 2025.
As an average over the last 3 years, UTMD stock has a PE ratio of 18.72.
As an average over the last 5 years, UTMD stock has a PE ratio of 21.69.
The highest quarterly PE ratio in the last ten years has been 43.37 and it was in the Jun 2018 quarter.
UTMD's price to earnings ratio is currently 35% below its 10-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jan 21, 2025), Utah Medical Products's stock price is $62.78. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $4.27. Therefore, Utah Medical Products's P/E ratio for today is 14.7. PE RATIO(14.7) = STOCK PRICE($62.78) / TTM EPS($4.27)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.